Clinical Trial Update: Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating raloxifene for prevention of bone loss in postmenopausal patients receiving chronic corticosteroid therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Evista (raloxifene)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED